Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |